Third Cardiovascular Giant Coming With $25 Bil. Abbott-St. Jude Deal
This article was originally published in The Gray Sheet
Executive Summary
The previously rumored acquisition was announced on April 28, with the firms touting their extensive synergies in the cardiovascular space.